Boddu, RSharma, AMishra, KKumar, S2024-12-072024-12-072024-01Boddu R, Sharma A, Mishra K, Kumar S. Rifampicin-induced thrombocytopenia in a patient with abdominal tuberculosis. Annals of the National Academy of Medical Sciences (India). 2024 Jan; 60(1): 26-290379-038X2454-5635https://imsear.searo.who.int/handle/123456789/241073Most anti-tubercular drugs are relatively safe, but adverse reactions are not uncommon. Rifampicin is one of the most effective and widely used antituberculosis drugs. Adverse effects due to rifampicin are not uncommon and the patients usually have skin rash, gastrointestinal disturbances, and hepatotoxicity. Rarely, the patients may also have allergic and autoimmune manifestations, which may include life-threatening thrombocytopenia. A high index of suspicion and careful evaluation for temporal association with the suspected drug are required to diagnose drug-induced immune thrombocytopenia. We present a case of rifampicin-induced thrombocytopenia; though relatively rare, it needs attention.ATTRifampicinThrombocytopeniaTuberculosisJournal ArticleIndiaDepartment of Clinical Hematology, Army Hospital (Research and ReferralDepartment of Pathology, Army Hospital (Research and Referral), New Delhi,IndiaDepartment of Clinical Hematology, Army Hospital (Research and Referral)Department of Clinical Hematology, Army Hospital (Research and Referral)